S&P 500   3,196.66 (-0.91%)
DOW   27,714.93 (-0.88%)
QQQ   219.71 (-0.76%)
AAPL   295.64 (-0.85%)
FB   200.36 (-0.18%)
MSFT   171.28 (+0.23%)
GOOGL   1,417.38 (-0.17%)
CGC   19.87 (-2.12%)
NVDA   263.04 (-3.75%)
MU   52.98 (-3.69%)
GE   11.44 (-3.54%)
TSLA   797.62 (-4.34%)
AMD   48.05 (-2.18%)
T   38.01 (-0.11%)
F   7.45 (-1.59%)
NFLX   363.24 (-1.48%)
S&P 500   3,196.66 (-0.91%)
DOW   27,714.93 (-0.88%)
QQQ   219.71 (-0.76%)
AAPL   295.64 (-0.85%)
FB   200.36 (-0.18%)
MSFT   171.28 (+0.23%)
GOOGL   1,417.38 (-0.17%)
CGC   19.87 (-2.12%)
NVDA   263.04 (-3.75%)
MU   52.98 (-3.69%)
GE   11.44 (-3.54%)
TSLA   797.62 (-4.34%)
AMD   48.05 (-2.18%)
T   38.01 (-0.11%)
F   7.45 (-1.59%)
NFLX   363.24 (-1.48%)
S&P 500   3,196.66 (-0.91%)
DOW   27,714.93 (-0.88%)
QQQ   219.71 (-0.76%)
AAPL   295.64 (-0.85%)
FB   200.36 (-0.18%)
MSFT   171.28 (+0.23%)
GOOGL   1,417.38 (-0.17%)
CGC   19.87 (-2.12%)
NVDA   263.04 (-3.75%)
MU   52.98 (-3.69%)
GE   11.44 (-3.54%)
TSLA   797.62 (-4.34%)
AMD   48.05 (-2.18%)
T   38.01 (-0.11%)
F   7.45 (-1.59%)
NFLX   363.24 (-1.48%)
S&P 500   3,196.66 (-0.91%)
DOW   27,714.93 (-0.88%)
QQQ   219.71 (-0.76%)
AAPL   295.64 (-0.85%)
FB   200.36 (-0.18%)
MSFT   171.28 (+0.23%)
GOOGL   1,417.38 (-0.17%)
CGC   19.87 (-2.12%)
NVDA   263.04 (-3.75%)
MU   52.98 (-3.69%)
GE   11.44 (-3.54%)
TSLA   797.62 (-4.34%)
AMD   48.05 (-2.18%)
T   38.01 (-0.11%)
F   7.45 (-1.59%)
NFLX   363.24 (-1.48%)
Log in

LON:SENS - Sensyne Health Share Price, Forecast & News

GBX 44
-1.00 (-2.22 %)
(As of 02/25/2020 10:58 AM ET)
Today's Range
44
Now: GBX 44
45.90
50-Day Range
39.50
MA: GBX 53.93
65.50
52-Week Range
35.30
Now: GBX 44
190
Volume7,736 shs
Average VolumeN/A
Market Capitalization£56.57 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. Read More…

Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
Phone44 3300 581845

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£489,000.00
Cash FlowGBX 25.67 per share
Book ValueGBX 43.40 per share

Profitability

Miscellaneous

Employees70
Market Cap£56.57 million
Next Earnings DateN/A
OptionableOptionable

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.


Sensyne Health (LON:SENS) Frequently Asked Questions

What is Sensyne Health's stock symbol?

Sensyne Health trades on the London Stock Exchange (LON) under the ticker symbol "SENS."

What price target have analysts set for SENS?

3 Wall Street analysts have issued 1 year price objectives for Sensyne Health's shares. Their forecasts range from GBX 195 to GBX 262. On average, they anticipate Sensyne Health's stock price to reach GBX 239 in the next year. This suggests a possible upside of 443.2% from the stock's current price. View Analyst Price Targets for Sensyne Health.

What is the consensus analysts' recommendation for Sensyne Health?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensyne Health in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sensyne Health.

Has Sensyne Health been receiving favorable news coverage?

Press coverage about SENS stock has been trending neutral on Tuesday, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sensyne Health earned a media sentiment score of 0.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Sensyne Health.

Who are some of Sensyne Health's key competitors?

What other stocks do shareholders of Sensyne Health own?

How do I buy shares of Sensyne Health?

Shares of SENS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Sensyne Health's stock price today?

One share of SENS stock can currently be purchased for approximately GBX 44.

How big of a company is Sensyne Health?

Sensyne Health has a market capitalization of £56.57 million and generates £489,000.00 in revenue each year. Sensyne Health employs 70 workers across the globe.View Additional Information About Sensyne Health.

What is Sensyne Health's official website?

The official website for Sensyne Health is http://www.sensynehealth.com/.

How can I contact Sensyne Health?

The company can be reached via phone at 44 3300 581845.


MarketBeat Community Rating for Sensyne Health (LON SENS)

Community Ranking:  3.8 out of 5 (star star star)
Outperform Votes:  56 (Thanks for Voting!)
Underperform Votes:  17 (Thanks for Voting!)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about Sensyne Health and other stocks. Vote "Outperform" if you believe SENS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SENS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel